Office of the Director
Nora D. Volkow, M.D.
Director
David Shurtleff, Ph.D.
Acting Deputy Director
Glenda Conroy, MBA, CPA, PMP, CIA, CISA
Associate Director for Management
Office of Management
Glenda Conroy, MBA, CPA, PMP, CIA, CISA
Director
Office of Extramural Affairs
Teresa Levitin, Ph.D.
Director
Office of Science Policy and Communications
Susan Weiss, Ph.D.
Acting Director
Division of Clinical Neuroscience and Behavioral Research
Joseph Frascella, Ph.D.
Director
Division of Epidemiology, Services and Prevention Research
Wilson M. Compton, M.D., M.P.E.
Director
Intramural Research Program
Antonello Bonci, M.D.
Scientific Director
Center for the Clinical Trials Network
Betty Tai, Ph.D.
Director
Division of Basic Neurosciences and Behavioral Research
Joni Rutter, Ph.D.
Acting Director
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
Phil Skolnick, Ph.D., D.Sc.
Director
Go Back To: Fiscal Year 2013 Budget Information - Congressional Justification for National Institute on Drug Abuse
Attention
Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at
Looking for Treatment?
Use the SAMHSA Treatment Locator or 1-800-662-HELP.
Helpline open during government shutdown